Alex Goldberg

NYSE Gainers Watch List: Wal-Mart Stores Inc. (NYSE:WMT) and Teva Pharmaceutical Industries Limited (NYSE:TEVA) Added to Equity Profile Report's NYSE Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 01/10/2014 -- Equity Profile Report expands its NYSE Gainers Weekly Watch List adding Wal-Mart Stores Inc. (NYSE:WMT) and Teva Pharmaceutical Industries Limited (NYSE:TEVA).

Wal-Mart Stores Inc. (NYSE:WMT) a company that operates retail stores in various formats worldwide closed up in its previous session (+0.33%) on 5,925,044 shares traded. Wal-Mart Stores Inc. (NYSE:WMT) is currently up (+15.77%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Gainers Watch List.

Click Here to find out what other Investors are saying about Wal-Mart Stores Inc. (NYSE:WMT)

Teva Pharmaceutical Industries Limited (NYSE:TEVA) a company that develops, manufactures, markets, and distributes pharmaceutical products worldwide closed up in its previous session (+1.27%) on 8,368,580 shares traded after Teva Named Erez Vigodman as President and CEO. Teva Pharmaceutical Industries Limited (NYSE:TEVA) is currently up (+14.75%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Gainers Watch List.

Click Here to find out what other Investors are saying about Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com